1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Lee Biosolutions Logo

Management of Testicular Germ Cell Tumors

Lee Biosolutions Inc Manufactures Serum Tumor Markers for Management of Testicular Germ Cell Tumors.

 
1 2 3 4 5 
Scientific Team Reviewing Data from Tumor Marker Purification
Scientific Team Reviewing Data from Tumor Marker Purification
PRLog - Nov. 14, 2012 - ST. LOUIS -- Lee Biosolutions Inc, a U.S. manufacturer, producer and supplier of high purity proteins and antigens announces the isolation and increased production of Serum Tumor Markers for the management of testicular germ cell tumors. The St. Louis-based healthcare- biotechnology firm has developed a unique proprietary process to effectively and efficiently purify beta Human Chorionic Gonadotropin, Alpha fetoprotein and Lactate dehydrogenase. As a result, Lee is now is a preferred producer for researchers and diagnostic companies to supply these critical components that are used in early detection of testicular cancer.

According to the American Cancer Society, there will be almost 9000 new cases of testicular cancer diagnosed in the United States this year. Although the rate of testicular cancer is rising for unknown reasons worldwide the death rate is low because of early detection and advances in the treatment of testicular cancer. Testicular cancer can develop in one or both testicles with over 90 percent of cancers in the testicle develop in special cells known as germ cells. Germ cells Scientists have found few risk factors that make a man more likely to develop testicular cancer.

Lee’s testicular germ cell tumor marker production capabilities enables in vitro diagnostics companies to manufacture diagnostic tests , which are affordable and higher quality. Lee has scaled up production to meet global market demand. Beta Human Chorionic Gonadotropin (Beta HCG), alpha fetoprotein (AFP) and Lactate Dehydrogenase (LDH) produced by Lee Biosolutions are used in the management of testicular germ cell tumors.

“Lee Biosolutions is on the forefront of Testicular Cancer research by supplying highly purified markers such as beta HCG, alpha fetoprotein and lactate dehydrogenase. Most testicular cancers are found by men themselves. If a lump is detected the doctor would recommend blood tests to determine levels of tumor markers to determine the proper diagnosis. Testicular cancer is survivable if treated early enough by the removal of the testicle. Its when you ignore the signs and you find yourself with Stage III cancer that has spread to the lungs, liver, bones and brain that survival rates diminish,” said Burton Lee, President of Lee Biosolutions.

Lee BioSolutions is an international producer and supplier of high purity finished proteins. Headquartered in St. Louis and founded in 2002, the healthcare biotechnology firm serves academic and scientific researchers as well as IVD manufacturers worldwide. Lee Bio has a big following on Facebook and encourages you to join in the conversation of the latest medical developments with LeeBio. Lee BioSolutions produces and processes raw biomaterials used in drug discovery and development, diagnostic controls and calibrators, clinical diagnosis and product testing. The company is ISO 9001:2008 certified, FDA registered and meets USDA guidelines. For more information go to Lee Biosolutions website at http://leebio.com

Photos:
http://www.prlog.org/12023469/1
http://www.prlog.org/12023469/2
http://www.prlog.org/12023469/3
http://www.prlog.org/12023469/4
http://www.prlog.org/12023469/5

--- End ---

Click to Share

Contact Email:
***@leebio.com Email Verified
Source:Lee Biosolutions, Inc
Phone:314-968-1091
Zip:63144
Location:St. Louis - Missouri - United States
Industry:Biotech, Health, Medical
Tags:Health, cancer, Medical, News, disease, enzyme, diagnostics, Research
Last Updated:Nov 14, 2012
Shortcut:prlog.org/12023469
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
9K2K1K
Click to Share